Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies of EN-1639A (naltrexone): a new narcotic antagonist.

× No keyword cloud information.

16 in total

1. Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose-effects and time-course.

Authors: George E Bigelow; Kenzie L Preston; John Schmittner; Qunming Dong; David R Gastfriend
Journal: Drug Alcohol Depend Date: 2011-11-12 Impact factor: 4.492

Review 2. Clinical safety of 1500 mg oral naltrexone overdose.

Authors: Albert Stuart Reece
Journal: BMJ Case Rep Date: 2010-09-07

Review 3. Molecular recognition of opioid receptor ligands.

Authors: Brian E Kane; Bengt Svensson; David M Ferguson
Journal: AAPS J Date: 2006-03-10 Impact factor: 4.009

Review 4. Oral naltrexone maintenance treatment for opioid dependence.

Authors: Silvia Minozzi; Laura Amato; Simona Vecchi; Marina Davoli; Ursula Kirchmayer; Annette Verster
Journal: Cochrane Database Syst Rev Date: 2011-04-13

Review 5. Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors: D I Quinn; A Wodak; R O Day
Journal: Clin Pharmacokinet Date: 1997-11 Impact factor: 6.447

6. Aversiveness of oral methadone in rats.

Authors: R E Chipkin; J A Rosecrans
Journal: Psychopharmacology (Berl) Date: 1978-05-31 Impact factor: 4.530

7. Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects.

Authors: P Grevert; A Goldstein
Journal: Proc Natl Acad Sci U S A Date: 1977-03 Impact factor: 11.205

8. Naltrexone-3-salicylate (a prodrug of naltrexone): synthesis and pharmacokinetics in dogs.

Authors: M A Hussain; E Shefter
Journal: Pharm Res Date: 1988-02 Impact factor: 4.200

9. Cinnamoyl derivatives of 7alpha-aminomethyl-6,14-endo-ethanotetrahydrothebaine and 7alpha-aminomethyl-6,14-endo-ethanotetrahydrooripavine and related opioid ligands.

Authors: David Rennison; Adrian P Neal; Gerta Cami-Kobeci; Mario D Aceto; Fernando Martinez-Bermejo; John W Lewis; Stephen M Husbands
Journal: J Med Chem Date: 2007-09-22 Impact factor: 7.446

Review 10. Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence.

Authors: J P Gonzalez; R N Brogden
Journal: Drugs Date: 1988-03 Impact factor: 9.546